Middletown, NEW%20JERSEY2 Active Studies

Atrial Fibrillation Clinical Trials in Middletown, NEW%20JERSEY

Find 2 actively recruiting atrial fibrillation clinical trials in Middletown, NEW%20JERSEY. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
90
Enrolling

Recruiting Atrial Fibrillation Studies in Middletown

About Atrial Fibrillation Clinical Trials in Middletown

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in Middletown, NEW%20JERSEY. These studies are seeking a combined 90 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Middletown — FAQ

Are there atrial fibrillation clinical trials in Middletown?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in Middletown, NEW%20JERSEY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Middletown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Middletown research site will contact you about next steps.

Are clinical trials in Middletown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Middletown studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in Middletown are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov